“…A large number of studies has illustrated that the abundance of these bacteria were lower in obese or type 2 diabetic rats or humans (Schwiertz et al, 2010; Gomez-Arango et al, 2016; Jung et al, 2016). By contrast, improvement of glucose and lipid metabolism by polyunsaturated fatty acids (Li et al, 2018), berberine fumarate (Cui et al, 2018), dietary fucoidan (Shang et al, 2017), oral hydroxysafflor yellow A (Liu et al, 2018), a leucine-deprived diet (Wei S. et al, 2018), a galacto-oligosaccharide-rich diet (Cheng et al, 2018) or a traditional Chinese medicine prescription-Xiexin Tang (Wei X. et al, 2018) were all positively correlated with the abundance of these bacterial species. SCFAs (mainly acetate and butyrate), which were produced by fermentation of indigestible dietary components by specific gut microbiota, appeared to promote epithelial restitution and have anti-inflammation activity (Sturm and Dignass, 2008).…”